Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Vasculitis Clinical Trials
Vasculitis clinical trials are recruiting across 50 cities. Here are the cities with the most active studies:
Vasculitis Trial Phases
9 research organizations are sponsoring vasculitis trials.
About Vasculitis
Vasculitis refers to a group of disorders that involve inflammation of blood vessels, which can restrict blood flow and damage organs. Types include ANCA-associated vasculitis, giant cell arteritis, and Takayasu arteritis. Treatment typically involves corticosteroids and immunosuppressive medications.
Clinical trials are advancing new treatments for vasculitis. Currently, 16 studies are recruiting a combined 7,252 participants across the United States. Research is being conducted by 9 organizations including National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), University of Pennsylvania, Amgen and 6 others.
2026 Vasculitis Research Landscape
As of July 2026, the vasculitis clinical trial landscape includes 16 actively recruiting studies across 50 cities in the United States. These studies are collectively seeking 7,252 participants, with an average enrollment target of 453 per study.
The research spans multiple phases of development: 4 studies are in PHASE2, 3 studies are in PHASE3, 2 studies are in PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some vasculitis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 9 different organizations, including National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), University of Pennsylvania, Amgen, Fate Therapeutics, Novartis Pharmaceuticals, and 4 others.
Geographically, vasculitis trials are most concentrated in Rochester, Minnesota (8 trials); Cleveland, Ohio (7 trials); Philadelphia, Pennsylvania (7 trials); Boston, Massachusetts (6 trials); New York, New York (4 trials) and 7 other cities.
Featured Vasculitis Studies
Highlighted recruiting studies for vasculitis, selected by enrollment size and research scope.
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the disease affects them. Objective: \- To learn the signs, symptoms, imaging tests, genetic markers, and...
One-Time DNA Study for Vasculitis
The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researc...
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is ...
Frequently Asked Questions About Vasculitis Clinical Trials
Are there vasculitis clinical trials near me?
Yes, there are 16 vasculitis clinical trials currently recruiting across 50+ cities in the United States, including Rochester, Minnesota; Cleveland, Ohio; Philadelphia, Pennsylvania. Browse the studies above to find one at a location convenient for you.
How do I join a vasculitis clinical trial?
To join a vasculitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are vasculitis clinical trials free?
Yes, participation in vasculitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of vasculitis treatments are being studied?
Current vasculitis clinical trials are testing a range of approaches across PHASE2 (4 studies), PHASE3 (3 studies), PHASE1 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 9 research organizations.
Is it safe to participate in vasculitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 19, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 19, 2026 · Data from ClinicalTrials.gov